Prion Protein of Extracellular Vesicle Regulates the Progression of Colorectal Cancer

Colorectal cancer (CRC) is one of the leading causes of cancer-related death due to its aggressive metastasis in later stages. Although there is a growing interest in the tumorigenic role of cellular prion protein (PrP<sup>C</sup>) in the process of metastasis, the precise mechanism behi...

Full description

Bibliographic Details
Main Authors: Chul-Won Yun, Jun-Hee Lee, Gyeongyun Go, Juhee Jeon, Sungtae Yoon, Sang-Hun Lee
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/9/2144
Description
Summary:Colorectal cancer (CRC) is one of the leading causes of cancer-related death due to its aggressive metastasis in later stages. Although there is a growing interest in the tumorigenic role of cellular prion protein (PrP<sup>C</sup>) in the process of metastasis, the precise mechanism behind the cellular communication involving prion proteins remains poorly understood. This study found that hypoxic tumor microenvironment increased the PrP<sup>C</sup>-expressing exosomes from CRC, and these exosomes regulate the CRC cell behavior and tumor progression depending on the expression of PrP<sup>C</sup>. Hypoxic exosomes from CRC cells promoted sphere formation, the expression of tumor-inducing genes, migration, invasion, and tumor growth. Furthermore, these exosomes increased endothelial permeability, migration, invasion, and angiogenic cytokine secretion. These effects were associated with PrP<sup>C</sup> expression. Application of anti-PrP<sup>C</sup> antibody with 5-fluorouracil significantly suppressed the CRC progression in a murine xenograft model. Taken together, these findings indicate that PrP-expressing exosomes secreted by hypoxic CRC cells are a key factor in the tumorigenic CRC-to-CRC and CRC-to-endothelial cell communication. Significance: These findings suggest that inhibiting PrP<sup>C</sup> in hypoxic exosomes during chemotherapy may be an effective therapeutic strategy in colorectal cancer.
ISSN:2072-6694